Trial Profile
White Matter and Emotional and Cognitive Control in Late-Onset Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 27 Aug 2019 Status changed from recruiting to completed.
- 26 Sep 2018 Planned End Date changed from 1 Jul 2018 to 1 Jul 2019.
- 26 Sep 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.